insights_auto
Outlook: 8.7% bullish·39.1% bearish
Go to analysischevron_right
S1YK34:BVMF
Stryker Corp Bdr
R$93.30
0.00%
(0.00) 1D
Nov 4, 5:54:30 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for S1YK34...
Mkt. cap
128.45B
Avg. vol.
924.00
Volume
0.00
52-wk high
R$100.16
52-wk low
R$67.62
Shares outstanding
380.69M
No. of employees
56K
Mkt. cap
128.45B
Avg. vol.
924.00
Volume
0.00
52-wk high
R$100.16
52-wk low
R$67.62
Shares outstanding
380.69M
No. of employees
56K
News stories
From web sources and news partners
Benzinga
·
20 minutes ago
Here's How Much $1000 Invested In Stryker 15 Years Ago Would Be Worth Today
Traders Union
·
21 hours ago
Stryker shares jump more than 9% after bullish technical momentum and UK robotics deal
Investing.com
·
3 days ago
Stifel cuts Stryker stock price target on weak quarter, guidance
MedTech Dive
·
3 weeks ago
Stryker enters soft tissue robotics with $400M investment in CMR Surgical
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp Bdr
CEOKevin A. Lobo
Employees56K
Founded1941
HeadquartersKalamazoo, Michigan, United States
SectorMedical device
Industry-
Websitestryker.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 7.17B | 6.02B | 6.59B | 6.52B |
Cost of goods sold | 2.49B | 2.19B | 2.08B | 2.25B |
Cost of revenue | 2.49B | 2.19B | 2.08B | 2.25B |
Research and development expenses | 388.00M | 409.00M | 429.00M | 423.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.15B | 2.16B | 2.13B | 2.17B |
Operating expense | 2.72B | 2.75B | 2.73B | 2.77B |
Total operating expenses | 5.22B | 4.95B | 4.81B | 5.02B |
Operating income | 1.95B | 1.07B | 1.78B | 1.50B |
Other non operating income | -33.00M | 19.00M | 1.00M | -91.00M |
EBT including unusual items | 1.70B | 850.00M | 1.56B | 997.00M |
EBT excluding unusual items | 1.81B | 987.00M | 1.68B | 1.41B |
Income tax expense | 856.00M | 105.00M | 288.00M | 244.00M |
Effective tax rate | 50.21% | 12.35% | 18.41% | 24.47% |
Other operating expenses | - | - | - | - |
Net income | 849.00M | 745.00M | 1.28B | 753.00M |
Net profit margin | 11.84% | 12.38% | 19.37% | 11.55% |
Earnings per share | 4.47 | 2.60 | 3.69 | 3.52 |
Interest and investment income | 31.00M | 34.00M | 26.00M | - |
Interest expense | -154.00M | -148.00M | -141.00M | - |
Net interest expenses | -123.00M | -114.00M | -115.00M | - |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 2.27B | 1.37B | 2.08B | 1.79B |
Gain or loss from assets sale | - | - | - | - |
Upcoming events